Connection

Marco Metra to Disease Management

Back to Details
This is a "connection" page, showing publications Marco Metra has written about Disease Management.
Marco Metra
Connection Strength
2.443
Disease Management
  1. Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Jun; 22(6):941-956.
    View in: PubMed
    Score: 0.232
  2. December 2018 at a glance: new imaging methods, translational cardiology and non-medical treatment. Eur J Heart Fail. 2018 12; 20(12):1613-1614.
    View in: PubMed
    Score: 0.207
  3. July 2018 at a glance: practical guidance in acute heart failure, pathophysiology and clinical trials of medical therapy. Eur J Heart Fail. 2018 07; 20(7):1079-1080.
    View in: PubMed
    Score: 0.201
  4. June 2018 at a glance: peripartum cardiomyopathy and pathophysiology, prognosis, and device therapy of heart failure. Eur J Heart Fail. 2018 06; 20(6):949-950.
    View in: PubMed
    Score: 0.200
  5. November 2017 at a glance: quality of care and disease management. Eur J Heart Fail. 2017 11; 19(11):1351-1352.
    View in: PubMed
    Score: 0.192
  6. October 2017 at a glance: phenotyping heart failure, co-morbidities, use of evidence-based therapy and new treatments. Eur J Heart Fail. 2017 10; 19(10):1216-1217.
    View in: PubMed
    Score: 0.191
  7. Points to consider for skin ulcers in systemic sclerosis. Rheumatology (Oxford). 2017 09 01; 56(suppl_5):v67-v71.
    View in: PubMed
    Score: 0.190
  8. Points to consider in renal involvement in systemic sclerosis. Rheumatology (Oxford). 2017 09 01; 56(suppl_5):v49-v52.
    View in: PubMed
    Score: 0.190
  9. July 2017 at a glance: clinical assessment, biomarkers, cardiac imaging and treatment. Eur J Heart Fail. 2017 07; 19(7):819-820.
    View in: PubMed
    Score: 0.188
  10. June 2017 at a glance: biomarkers and medical treatment. Eur J Heart Fail. 2017 06; 19(6):699-700.
    View in: PubMed
    Score: 0.187
  11. April 2017 at a glance: cardiomyopathies and clinical trials. Eur J Heart Fail. 2017 04; 19(4):447-448.
    View in: PubMed
    Score: 0.185
  12. Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study. Clin Exp Med. 2019 Aug; 19(3):357-366.
    View in: PubMed
    Score: 0.053
  13. January 2019 at a glance: prognostic assessment, left ventricular assist devices, disease management and quality of care. Eur J Heart Fail. 2019 01; 21(1):1-2.
    View in: PubMed
    Score: 0.052
  14. Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2018 05 01; 57(5):813-817.
    View in: PubMed
    Score: 0.050
  15. Acute heart failure: lessons learned, roads ahead. Eur J Heart Fail. 2018 05; 20(5):842-850.
    View in: PubMed
    Score: 0.049
  16. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail. 2018 04; 20(4):700-710.
    View in: PubMed
    Score: 0.048
  17. Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? Eur J Heart Fail. 2019 07; 21(7):852-861.
    View in: PubMed
    Score: 0.013
  18. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019 May; 21(5):553-576.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.